A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice.

Douros, Jonathan D et al.·Molecular metabolism·2025·
RPEP-107632025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice.
Published In:
Molecular metabolism, 100, 102124 (2025)
Database ID:
RPEP-10763

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-10763·https://rethinkpeptides.com/research/RPEP-10763

APA

Douros, Jonathan D; Novikoff, Aaron; DuBois, Barent; Rohlfs, Rebecca; Mokrosinski, Jacek; Hogendorf, Wouter F J; Augustin, Robert; Merkestein, Myrte; Egaa Martini, Lene Brandt; Linderoth, Lars; Gerrard, Elliot; Kodra, Janos Tibor; Norlin, Jenny; Roed, Nikolaj Kulahin; Oldenburger, Anouk; Mowery, Stephanie A; Waldhoer, Maria; Perez-Tilve, Diego; Finan, Brian; Reedtz-Runge, Steffen; Müller, Timo D; Knerr, Patrick J. (2025). A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice.. Molecular metabolism, 100, 102124. https://doi.org/10.1016/j.molmet.2025.102124

MLA

Douros, Jonathan D, et al. "A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice.." Molecular metabolism, 2025. https://doi.org/10.1016/j.molmet.2025.102124

RethinkPeptides

RethinkPeptides Research Database. "A GLP-1 analogue optimized for cAMP-biased signaling improve..." RPEP-10763. Retrieved from https://rethinkpeptides.com/research/douros-2025-a-glp1-analogue-optimized

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.